Projects overview

Sort by


Toggle all information

IN-ARMOR | THERAPEUTIC EPIGENETIC ENHANCEMENT OF THE INNATE IMMUNITY TO EFFECTIVELY COMBAT ANTIMICROBIAL RESISTANCE [IN-ARMOR]

01-05-2023

-

30-04-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

PHOENIX | NANOMEDICINE FOR ORGAN TRANSPLANTATION TOLERANCE (PHOENIX)

01-04-2023

-

31-03-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

NEXGEN-PD | Next Generation Vaccine Platform Leveraging Skin Immunity to Provide Disease-Modifying Treatment of Parkinson’s Disease

01-04-2023

-

31-03-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

TiilT | Preclinical development of a 3rd-generation interleukin-2 targeted to inflammatory sites

01-06-2023

-

31-05-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

MITI 2 | Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2)

01-05-2023

-

30-04-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

ARTiDe | Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe)

01-07-2023

-

30-06-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

UltiMalVax | A Vaccine Targeting Eradication of Malaria

01-05-2023

-

30-04-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-03-two-stage Vaccines 2.0 - developing the next generation of vaccines

FIBROTARGET | Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseases

01-04-2023

-

31-03-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

TBVAC-HORIZON | Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity

01-04-2023

-

31-03-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-03-two-stage Vaccines 2.0 - developing the next generation of vaccines

Vax2Muc | NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MODEL PATHOGEN

01-07-2023

-

30-06-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-03-two-stage Vaccines 2.0 - developing the next generation of vaccines

NOSEVAC | INNOVATIVE NASAL VACCINES TO PREVENT PATHOGEN COLONIZATION AND INFECTION IN THE UPPER RESPIRATORY TRACT

01-05-2023

-

30-04-2028

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-03-two-stage Vaccines 2.0 - developing the next generation of vaccines

IMMUTOL | ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES

01-05-2023

-

30-04-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2022-DISEASE-06-two-stage
HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs

COMMUTE | COMORBIDITY MECHANISMS UTILIZED IN HEALTHCARE

01-12-2023

-

30-11-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2023-DISEASE-03
HORIZON-HLTH-2023-DISEASE-03-07 Relationship between infections and non-communicable diseases

DRAIGON | Diagnosing Infections with Multi-Drug Resistant Microorganisms using AI-powered Genomic Antibiotic Susceptibility Prediction from Long-Read Sequencing Data

01-01-2024

-

31-12-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2023-TOOL-05
HORIZON-HLTH-2023-TOOL-05-08 Pandemic preparedness and response: In vitro diagnostic devices to tackle cross-border health threats

HERVCOV | SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients

01-07-2022

-

30-06-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-07 Personalised medicine and infectious diseases: understanding the individual host response to viruses (e.g. SARS-CoV-2)

BE READY | Building a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness

01-06-2022

-

31-05-2025

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-06 Building a European partnership for pandemic preparedness

REACT | Respiratory Host-Pathogen Interaction

01-08-2022

-

31-07-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-07 Personalised medicine and infectious diseases: understanding the individual host response to viruses (e.g. SARS-CoV-2)

EChiLiBRiST | Development and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survival

01-09-2022

-

31-08-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-03 Innovative approaches to enhance poverty-related diseases research in sub-Saharan Africa

UNDINE | The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine

01-06-2022

-

31-05-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-07 Personalised medicine and infectious diseases: understanding the individual host response to viruses (e.g. SARS-CoV-2)

D-SOLVE | Understanding the individual host response against Hepatitis D Virus to develop a personalized approach for the management of hepatitis D

01-10-2022

-

30-09-2026

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-07 Personalised medicine and infectious diseases: understanding the individual host response to viruses (e.g. SARS-CoV-2)

ADVANCE-VAC4PM | Advancing The Clinical Development Of Placental Malaria Vaccines In The Context Of Capacity Building and Use Of Digital Health Technologies

01-06-2022

-

31-05-2027

Show more information
EU-Programme-Call
Horizon Europe
HORIZON.2 Global Challenges and European Industrial Competitiveness
HORIZON.2.1 Health
HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases
HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04-03 Innovative approaches to enhance poverty-related diseases research in sub-Saharan Africa
Powered by Chris Decubber BV